ctDNA
circulating tumor DNA — Fragments of tumor DNA in the blood, used for non-invasive cancer detection and monitoring.
Coverage of ctDNA is holding steady : 28 signals on the latest tracked day, up 100% from its three-week baseline of 14, across 3 domains (unchanged from a week ago). That makes it the #68 most-covered of the 289 concerns we track.
What’s changed
- High-dose furmonertinib plus bevacizumab and intrathecal pemetrexed for EGFR-RAD51 fusion-positive lung adenocarcinoma with leptomeningeal metastasis: Insights from serial CSF ctDNA monitoring · European Journal of Cancer · 2026-08-16
- ctDNA Detection of Polyclonal KRAS Resistance in Adagrasib-Treated NSCLC. · Thorac Cancer · 2026-08-01
- Discordant Dynamics Between Absolute ctDNA and Tumor Fraction During Treatment Monitoring in Metastatic Colorectal Cancer: Evidence of a Dilution Phenomenon · Clinical Colorectal Cancer · 2026-07-25
- ctDNA-guided adjuvant therapy in stage II colon cancer: a step forward, but not the final word · Annals of Oncology · 2026-07-19
- Does ctDNA-Guided Surveillance After Curative-Intent Surgery Benefit Outcomes in Cases of Recurrent Colorectal Cancer - The ASCO Post · Colorectal Cancer Treatment (Google News) · 2026-08-13 · usually covers CRC Treatment
- Vivek Subbiah: Use of CtDNA May Help Select Best Treatment and Timing of Therapy · OncoDaily · 2026-08-11 · usually covers Industry News
What the reporting says
It shows up alongside Colorectal Cancer (96), Immunotherapy (15), KRAS (15), Pancreatic Cancer (8), Clinical Oncology (10), Abstract (17), AI (13), ASCO (11).
Two steps out: Wang (through Colorectal Cancer, 55 shared stories on the weaker link); MSI-H (through Colorectal Cancer, 53 shared stories on the weaker link); Zhang (through Colorectal Cancer, 49 shared stories on the weaker link); Braf (through Colorectal Cancer, 47 shared stories on the weaker link).
Tracked since Mar 11, with coverage on 91 separate days — concentrated in Oncology and Pubmed Targeted.